Evidence-Based Medicine Guidelines
Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Calcium-channel Blockers for Raynaud's Phenomenon in Systemic Sclerosis." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457163/all/Calcium_channel_blockers_for_Raynaud&apos.
Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/457163/all/Calcium_channel_blockers_for_Raynaud&apos. Accessed February 7, 2026.
Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/457163/all/Calcium_channel_blockers_for_Raynaud&apos
Calcium-channel Blockers for Raynaud's Phenomenon in Systemic Sclerosis [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2026 February 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457163/all/Calcium_channel_blockers_for_Raynaud&apos.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis
ID - 457163
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457163/all/Calcium_channel_blockers_for_Raynaud&apos
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
